Wayne Kelly, MD
Interventional Pain Medicine · Rolling Meadows, ILNPI 1164519005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $766 of the $1,051 with a category attached, or 72.9%. 14 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 31.8% of the total. Reporting peaked in 2019 at $421 and has fallen 83.4% since, to $70 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 44 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$334
- Depuy Synthes Products, Inc.$285
- Amgen$83
- Lilly USA, LLC$80
- Vertex$54
- Supernus Pharmaceuticals, Inc.$52
- plus $163 from 8 others
What the payments were for
- Travel & lodging$28527%
- Food & beverage$76673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 17 | $334 |
| Depuy Synthes Products, Inc. | 1 | $285 |
| Amgen(2 entities) | 6 | $83 |
| Lilly USA, LLC | 4 | $80 |
| Vertex | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 4 | $52 |
| Biodelivery Sciences International, Inc. | 2 | $31 |
| Scilex Pharmaceuticals Inc. | 2 | $25 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Shionogi Inc | 1 | $18 |
| AbbVie | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Valinor Pharma, LLC | 1 | $16 |
How this compares
$1,051 in reported general payments places this provider in the 35th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 29 | $43,775 |
| OxycontinOxycodone Hcl | 15 | $20,503 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 420 | $19,300 |
| Fentanyl | 117 | $14,734 |
| Oxycodone Hcl | 414 | $14,409 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 300 | $13,994 |
| Morphine Sulfate ErMorphine Sulfate | 323 | $10,708 |
| Lidocaine | 21 | $6,442 |
| Morphine Sulfate | 74 | $2,620 |
| Methadone Hcl | 87 | $2,054 |
| Gabapentin | 103 | $1,597 |
| Cyclobenzaprine Hcl | 93 | $1,130 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 41 | $911 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $611 |
| Duloxetine Hcl | 44 | $584 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $334 | $43,77529 claims |
| Upsher-smith Laboratories LLCTopiramate | $20 | $46465 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 93 interventional pain medicine providers in Illinois.
Other interventional pain medicine in Rolling Meadows
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
- Jay JoshiDeer Park$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.